• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与结直肠癌

Non-alcoholic fatty liver disease and colorectal cancer.

作者信息

Mikolasevic I, Orlic L, Stimac D, Hrstic I, Jakopcic I, Milic S

机构信息

Department of Gastroenterology, UHC Rijeka, Rijeka, Croatia.

Department of Nephrology, Dialysis and Kidney Transplantation, UHC Rijeka, Rijeka, Croatia.

出版信息

Postgrad Med J. 2017 Mar;93(1097):153-158. doi: 10.1136/postgradmedj-2016-134383. Epub 2016 Nov 16.

DOI:10.1136/postgradmedj-2016-134383
PMID:27852946
Abstract

As a significant cause of cancer death worldwide, colorectal cancer (CRC) is still one of the most common cancers in the world. The most efficient strategies to reduce CRC incidence include identifying risk factors for CRC and performing a preventive colonoscopy in high-risk populations. Some well-established risk factors for CRC development include hereditary syndromes and inflammatory bowel disease. Of note, in recent years, attention has been given to new evidence indicating that more than 75%-95% of CRC occurs in individuals with little or no genetic risk. For these individuals, the risk for CRC is associated with their lifestyle and dietary factors, including central obesity, overweight and physical inactivity. Recently, evidence demonstrated a connection between non-alcoholic fatty liver disease (NAFLD) and CRC. Insulin resistance and metabolic syndrome (MetS) are common risks that NAFLD and colorectal neoplasms share. The incidence of NAFLD is increasing in parallel with an increasing prevalence of MetS and obesity. Consequently, the question arises: will the incidence of CRC increase together with this dramatic increase in obesity, MetS and ultimately NAFLD prevalence? Recent studies of adenomatous polyps, CRC and NAFLD are discussed in this manuscript.

摘要

作为全球癌症死亡的一个重要原因,结直肠癌(CRC)仍然是世界上最常见的癌症之一。降低结直肠癌发病率的最有效策略包括识别结直肠癌的风险因素,并在高危人群中进行预防性结肠镜检查。一些已明确的结直肠癌发生风险因素包括遗传综合征和炎症性肠病。值得注意的是,近年来,人们开始关注新的证据,这些证据表明超过75%-95%的结直肠癌发生在遗传风险很小或没有遗传风险的个体中。对于这些个体,结直肠癌的风险与其生活方式和饮食因素有关,包括中心性肥胖、超重和缺乏身体活动。最近,有证据表明非酒精性脂肪性肝病(NAFLD)与结直肠癌之间存在联系。胰岛素抵抗和代谢综合征(MetS)是NAFLD和结直肠肿瘤共有的常见风险。NAFLD的发病率随着MetS和肥胖患病率的增加而平行上升。因此,问题来了:结直肠癌的发病率会随着肥胖、MetS以及最终NAFLD患病率的急剧上升而一起增加吗?本文讨论了最近关于腺瘤性息肉、结直肠癌和NAFLD的研究。

相似文献

1
Non-alcoholic fatty liver disease and colorectal cancer.非酒精性脂肪性肝病与结直肠癌
Postgrad Med J. 2017 Mar;93(1097):153-158. doi: 10.1136/postgradmedj-2016-134383. Epub 2016 Nov 16.
2
The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.非酒精性脂肪性肝病与代谢综合征在结肠镜检查结直肠肿瘤方面的关系。
Medicine (Baltimore). 2017 Jan;96(2):e5809. doi: 10.1097/MD.0000000000005809.
3
The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer.非酒精性脂肪性肝病进展为结直肠癌肝转移的风险。
Expert Rev Gastroenterol Hepatol. 2019 Dec;13(12):1169-1180. doi: 10.1080/17474124.2019.1697231. Epub 2019 Nov 29.
4
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
5
Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.非酒精性脂肪性肝病的全身并发症:当肝脏并非无辜旁观者时
Semin Liver Dis. 2015 Aug;35(3):236-49. doi: 10.1055/s-0035-1562944. Epub 2015 Sep 17.
6
Nonalcoholic fatty liver disease - A multisystem disease?非酒精性脂肪性肝病——一种多系统疾病?
World J Gastroenterol. 2016 Nov 21;22(43):9488-9505. doi: 10.3748/wjg.v22.i43.9488.
7
The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies.非酒精性脂肪性肝病与结直肠腺瘤和癌症发病及复发风险的关系:观察性研究的荟萃分析。
Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):385-395. doi: 10.1080/17474124.2019.1580143. Epub 2019 Feb 19.
8
Association between non-alcoholic fatty liver disease and colorectal cancer.非酒精性脂肪性肝病与结直肠癌的相关性。
Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):633-641. doi: 10.1080/17474124.2019.1617696. Epub 2019 May 20.
9
Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps.非酒精性脂肪性肝病与结直肠腺瘤性息肉的关系。
J Gastroenterol Hepatol. 2010 Mar;25(3):562-7. doi: 10.1111/j.1440-1746.2009.06117.x. Epub 2010 Jan 13.
10
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?代谢综合征与非酒精性脂肪性肝病:胰岛素抵抗是其中的关联因素吗?
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24.

引用本文的文献

1
Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis.通过转录组学分析探索常见基因组生物标志物,以揭示用于治疗伴有2型糖尿病的结直肠癌和肝细胞癌的常见药物。
PLoS One. 2025 Mar 24;20(3):e0319028. doi: 10.1371/journal.pone.0319028. eCollection 2025.
2
Steatosis is not associated with increased risk of chemotherapy-associated liver injury in metastatic colorectal cancer.在转移性结直肠癌中,肝脂肪变性与化疗相关肝损伤风险增加无关。
eGastroenterology. 2025 Mar 7;3(1):e100157. doi: 10.1136/egastro-2024-100157. eCollection 2025.
3
Association between surrogate indices of fatty liver and the risk of colorectal cancer: a cross-sectional United States study.
脂肪肝替代指标与结直肠癌风险之间的关联:一项美国横断面研究。
Transl Cancer Res. 2025 Jan 31;14(1):313-326. doi: 10.21037/tcr-24-1444. Epub 2025 Jan 23.
4
Nonalcoholic fatty liver disease and colorectal cancer: a two-sample bidirectional Mendelian randomization analysis.非酒精性脂肪性肝病与结直肠癌:两样本双向孟德尔随机化分析。
Eur J Gastroenterol Hepatol. 2024 Dec 1;36(12):1447-1452. doi: 10.1097/MEG.0000000000002859. Epub 2024 Oct 30.
5
Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies.代谢功能障碍相关脂肪性肝病与结直肠癌或结直肠腺瘤风险之间的关联:队列研究的最新荟萃分析
Front Oncol. 2024 Jul 9;14:1368965. doi: 10.3389/fonc.2024.1368965. eCollection 2024.
6
Liver Disease as a Potential Risk Factor for Colorectal Cancer: A Community Hospital Experience.肝病作为结直肠癌的潜在危险因素:一家社区医院的经验
Cureus. 2024 Jun 14;16(6):e62400. doi: 10.7759/cureus.62400. eCollection 2024 Jun.
7
Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration.结直肠转移肝切除术前肝脂肪变性的处理:叙述性综述及病例说明。
Nutrients. 2022 Dec 15;14(24):5340. doi: 10.3390/nu14245340.
8
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep's Clothing?非酒精性脂肪性肝病与肝外癌症:披着羊皮的狼?
Curr Oncol. 2022 Jun 25;29(7):4478-4510. doi: 10.3390/curroncol29070356.
9
Correlation Analysis Between Trace Elements and Colorectal Cancer Metabolism by Integrated Serum Proteome and Metabolome.整合血清蛋白质组和代谢组学分析微量元素与结直肠癌代谢的相关性。
Front Immunol. 2022 Jun 2;13:921317. doi: 10.3389/fimmu.2022.921317. eCollection 2022.
10
Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病患者结直肠肿瘤的部位特异性风险:系统评价和荟萃分析。
PLoS One. 2021 Jan 25;16(1):e0245921. doi: 10.1371/journal.pone.0245921. eCollection 2021.